<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="editorial" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Eur J Psychotraumatol</journal-id>
<journal-id journal-id-type="iso-abbrev">Eur J Psychotraumatol</journal-id>
<journal-id journal-id-type="archive">ZEPT</journal-id>
<journal-id journal-id-type="publisher-id">zept20</journal-id>
<journal-title-group>
<journal-title>European Journal of Psychotraumatology</journal-title>
</journal-title-group>
<issn pub-type="epub">2000-8066</issn>
<publisher>
<publisher-name>Taylor &amp; Francis</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28680541</article-id>
<article-id pub-id-type="pmc">5492080</article-id>
<article-id pub-id-type="publisher-id">1341824</article-id>
<article-id pub-id-type="doi">10.1080/20008198.2017.1341824</article-id>
<article-categories>
<subj-group subj-group-type="article-type">
<subject>Editorial</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Editorial</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Understanding the cellular and molecular alterations in PTSD brains: The necessity of post-mortem brain tissue</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>de Lange</surname>
<given-names>Geertje M.</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">
<sup>a</sup>
</xref>
<xref ref-type="corresp" rid="AN0001">
<sup>*</sup>
</xref>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0420-4559</contrib-id>
</contrib>
<aff id="AFF0001"><label><sup>a</sup></label><institution><named-content content-type="department">NBB-Psy, Netherlands Brain Bank</named-content>, <named-content content-type="institution-name">Netherlands Institute for Neuroscience</named-content></institution>, <named-content content-type="city">Amsterdam</named-content>, <country>The Netherlands</country></aff>
</contrib-group>
<author-notes>
<corresp id="AN0001">CONTACT Geertje M. de Lange <email xlink:href="1geertjedelange1@gmail.com">1geertjedelange1@gmail.com</email><institution><named-content content-type="department">NBB-Psy</named-content>, <named-content content-type="institution-name">University Medical Center Utrecht</named-content></institution>, Heidelberglaan 100, <named-content content-type="postal-code">3584</named-content>, <named-content content-type="state">CX</named-content>, <named-content content-type="city">Utrecht</named-content>, <country>Netherlands</country></corresp>
</author-notes>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>26</day>
<month>6</month>
<year>2017</year>
</pub-date>
<volume>8</volume>
<issue>1</issue>
<elocation-id>1341824</elocation-id>
<history>
<date date-type="received">
<day>7</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>9</day>
<month>6</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>The Author(s)</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="zept-8-1341824.pdf" xlink:type="simple"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>The personal, social and economic burden of post-traumatic stress disorder (PTSD) is high and therapeutic approaches are only partially effective. Therefore, there is an urgent need to understand the cellular and molecular alterations in PTSD brains in order to design more effective treatment strategies. Although brain imaging strategies have considerably improved our understanding of PTSD, these strategies cannot identify molecular and cellular changes. Post-mortem examination of the brain is a crucial strategy to advance our understanding of the underlying neuropathology, neurochemistry and molecular pathways of PTSD. Unfortunately, there is a worldwide serious shortage of human psychiatric brain tissue available for post-mortem research. Therefore, the Netherlands Brain Bank launched a prospective donor programme to recruit brain donors with psychiatric diseases in 2012: Netherlands Brain Bank for Psychiatry (NBB-Psy). NBB-Psy aims to establish a resource of brain tissue of seven psychiatric disorders: post-traumatic stress disorder, major depressive disorder, schizophrenia, bipolar disorder, obsessive-compulsive disorder, autism spectrum disorder, and attention-deficit hyperactivity disorder. Participants of several large and clinically characterized research cohorts of psychiatric patients, including relatives and controls, were asked prospectively to register as brain donors. Registered donors complete medical questionnaires annually. The number of registered donors with a psychiatric disorder at the NBB has risen from 312 (most of which were patients with major depressive disorder) in the year 2010 to 1187 in 2017, of which 146 are PTSD patients. The NBB guarantees worldwide open access to biomaterials and data. Any researcher affiliated with a research institute can apply.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>KEYWORDS</title>
<kwd>Brain Bank</kwd>
<kwd>post mortem</kwd>
<kwd>PTSD</kwd>
<kwd>psychiatry</kwd>
<kwd>brain tissue</kwd>
<kwd>post-traumatic stress disorder</kwd>
<kwd>prospective donor programme</kwd>
</kwd-group>
<funding-group>
<funding-statement>The NBB-Psy project is financed by The Netherlands Organisation for Scientific Research (NWO) grant 240-921200.</funding-statement>
</funding-group>
<counts>
<ref-count count="21"></ref-count>
<page-count count="4"></page-count>
</counts>
</article-meta>
</front>
<body>
<p>The personal, social and economic burden of post-traumatic stress disorder (PTSD) is high and therapeutic approaches such as prolonged exposure, EMDR, cognitive therapy, and paroxetine and sertraline are only partially effective (Bradley, Greene, Russ, Dutra, &amp; Westen, <xref ref-type="bibr" rid="CIT0002">2005</xref>; Nijdam &amp; Olff, <xref ref-type="bibr" rid="CIT0011">2016</xref>; Schnyder et al., <xref ref-type="bibr" rid="CIT0016">2015</xref>; Steenkamp, Litz, Hoge, &amp; Marmar, <xref ref-type="bibr" rid="CIT0018">2015</xref>). Besides, intense emotions triggered by psychotherapy can be intolerable and can lead to poor compliance (Taylor, <xref ref-type="bibr" rid="CIT0020">2006</xref>) and it remains unknown which clients are more likely to benefit from which treatment method (Olff et al., <xref ref-type="bibr" rid="CIT0013">2015</xref>; Seidler &amp; Wagner, <xref ref-type="bibr" rid="CIT0017">2006</xref>). Therefore, there is an urgent need to understand the cellular and molecular alterations in PTSD brains in order to design more effective treatment strategies. PTSD is a classic example of how brain functions can change as a consequence of an external event. The symptoms of PTSD reflect a persistent, inadequate adaptation of neurobiological systems to the stress of an experienced or witnessed trauma (Lanius &amp; Olff, <xref ref-type="bibr" rid="CIT0007">2017</xref>; Marinova &amp; Maercker, <xref ref-type="bibr" rid="CIT0009">2015</xref>). Neuroimaging studies have demonstrated significant neurobiological changes in PTSD, namely alterations in volume, connectivity and activity, involving the hippocampus, amygdala and the medial frontal cortex (Fragkaki, Thomaes, &amp; Sijbrandij, <xref ref-type="bibr" rid="CIT0006">2016</xref>; Lanius, Frewen, Tursich, Jetly, &amp; McKinnon, <xref ref-type="bibr" rid="CIT0008">2015</xref>; Nutt &amp; Malizia, <xref ref-type="bibr" rid="CIT0012">2004</xref>; Quidé, Witteveen, El-Hage, Veltman, &amp; Olff, <xref ref-type="bibr" rid="CIT0014">2012</xref>). Athough brain imaging strategies have considerably improved our understanding of PTSD, these strategies cannot identify molecular and cellular changes. In addition, animal models of psychiatric disorders have limited validity because they do not reflect the complexity of the human brain and because some symptoms such as suicidality cannot be simulated in animal models. Furthermore, a blueprint of processes in the brain is not likely to be found in peripheral material (e.g. blood), because of the intact blood–brain barrier in psychiatric disorders and the unique properties of brain tissue. Given these limitations, post-mortem examination of the brain is a crucial strategy to advance our understanding of the underlying neuropathology, neurochemistry and molecular pathways of PTSD. And yet, post-mortem studies on PTSD are rare. Literature search only shows two studies in which only nine PTSD brains were examined (Bracha, Garcia-Rill, Mrak, &amp; Skinner, <xref ref-type="bibr" rid="CIT0001">2005</xref>; Su et al., <xref ref-type="bibr" rid="CIT0019">2008</xref>). Bracha et al. (<xref ref-type="bibr" rid="CIT0001">2005</xref>) found reduced numbers of locus coeruleus neurons in the brains of three elderly male veterans with possible PTSD compared to four controls. Su et al. (<xref ref-type="bibr" rid="CIT0019">2008</xref>) analysed mitochondrial gene expression in six PTSD brain samples and identified mitochondrial dysfunction in the dorsolateral prefrontal cortex in PTSD that may prove useful to improve diagnosis and treatment of PTSD. The rarity of post-mortem studies on PTSD is a direct reflection of the worldwide serious shortage of human psychiatric brain tissue available for post-mortem research.
</p>
<sec id="S0002">
<label>1.</label>
<title>Brain Banks worldwide</title>
<p>Only a limited number of Brain Banks have collected post-mortem psychiatric brains for research purposes of which only some include also PTSD cases (Deep-Soboslay et al., <xref ref-type="bibr" rid="CIT0004">2011</xref>). Therefore, several initiatives to increase numbers of PTSS cases were launched worldwide, such as the McLean’s Harvard Brain Tissue Resource Center, the Leahy-Friedman National PTSD Brain Bank in Boston (Thompson, <xref ref-type="bibr" rid="CIT0021">2015</xref>), but also our initiative in the Netherlands.</p>
<p>Unfortunately, in many cases Brain Banks lack clinical information of the donors, specifically detailed information on the course of the disease and drug use that was collected in a standardized manner. Such information is crucial for interpreting findings in the brain. Consequently, there is an urgent need for well-documented and high quality human brain tissue from patients with psychiatric disorders.</p>
</sec>
<sec id="S0003">
<label>2.</label>
<title>Netherlands Brain Bank for psychiatry</title>
<p>The Netherlands Brain Bank (NBB) launched a prospective donor programme to recruit brain donors with psychiatric diseases in 2012: the Netherlands Brain Bank for Psychiatry (NBB-Psy) (Rademaker, De Lange, &amp; Palmen, <xref ref-type="bibr" rid="CIT0015">in press</xref>). NBB-Psy aims to establish a resource of brain tissue of seven major psychiatric disorders: PTSD, major depressive disorder, schizophrenia, bipolar disorder, obsessive-compulsive disorder, autism spectrum disorder, and attention-deficit hyperactivity disorder. To accomplish this, together with research groups of five Dutch Academic Medical Centers we developed a strategy based on two strong assets in the Netherlands. First, the NBB is one of the world’s leading Brain Banks and well known for its rapid fresh dissection protocols (4–10 hours after death). Second, the availability of several large and clinically characterized research cohorts of psychiatric patients, including relatives and controls. Participants of these cohorts were asked prospectively to register as brain donors at the NBB. Additionally, we approached patient organizations, we asked long-stay and specialized clinics to exhibit our brochures in the waiting areas, and we launched a national campaign in which we made an appeal through radio, television and billboards to register as brain donor. We invited registered donors to cooperate with a psychiatric interview and complete annual medical questionnaires. State-of-the-art neuropathological diagnoses are performed for each donor. A full clinical and neuropathological report accompanies each entry of available tissue at the NBB. Paraffin and frozen tissue blocks from standard regions from both hemispheres are available for researchers. Furthermore, the NBB is the only Brain Bank in the world that enriches the material by acute isolation of pure glial cells which are increasingly important as they are more and more recognized as key players in the pathophysiology of psychiatric disorders (Chung, Welsh, Barres, &amp; Stevens, <xref ref-type="bibr" rid="CIT0003">2015</xref>; Elsayed &amp; Magistretti, <xref ref-type="bibr" rid="CIT0005">2015</xref>; Mizee, van der Poel, &amp; Huitinga, <xref ref-type="bibr" rid="CIT0010">in press</xref>). One hallmark enrichment strategy of NBB-Psy is to isolate, characterize, and store microglia. A similar project is underway for the isolation of astrocytes. In addition, pluripotent stem cell lines that have been generated from donor fibroblasts are available, enabling researchers to study disorder-specific glial cells and neurons.</p>
</sec>
<sec id="S0004">
<label>3.</label>
<title>Worldwide open access</title>
<p>Since NBB-Psy started, the number of registered donors with a psychiatric disorder at the NBB has risen from 312 (most of which were patients with major depressive disorder) in the year 2010 to 1187 in 2017, of which 146 PTSD patients. The NBB guarantees worldwide open access to biomaterials and data. Any researcher affiliated with a research institute can apply. This resource of brain tissue allows researchers to address questions such as: (1) Are the numbers of neuronal or glial cells altered in specific brain regions? (2) Are the morphology and phenotype of these cells altered in specific brain regions? (3) Is there a change in neuronal function? (4) Are there synaptic abnormalities? (5) Which molecular pathways are affected? Addressing these questions is a crucial step towards advanced understanding of PTSD and other psychiatric disorders. The ultimate goal of NBB-Psy is to facilitate the development of better treatment strategies and a better quality of life for people with psychiatric disorders and their relatives.</p>
</sec>
</body>
<back>
<sec id="S0005">
<title>Disclosure statement</title>
<p>No potential conflict of interest was reported by the author.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="CIT0001">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bracha</surname><given-names>H. S.</given-names></name>, <name><surname>Garcia-Rill</surname><given-names>E.</given-names></name>, <name><surname>Mrak</surname><given-names>R. E.</given-names></name>, &amp; <name><surname>Skinner</surname><given-names>R.</given-names></name></person-group> (<year>2005</year>). <article-title>Postmortem locus coeruleus neuron count in three american veterans with probable or possible war-related PTSD</article-title>. <source/><italic>The Journal of Neuropsychiatry and Clinical Neurosciences</italic>, <volume>17</volume>(<issue>4</issue>), <fpage>503</fpage>–<lpage>3</lpage>. doi:<pub-id pub-id-type="doi">10.1176/jnp.17.4.503</pub-id>
<pub-id pub-id-type="pmid">16387990</pub-id></mixed-citation>
</ref>
<ref id="CIT0002">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bradley</surname><given-names>R.</given-names></name>, <name><surname>Greene</surname><given-names>J.</given-names></name>, <name><surname>Russ</surname><given-names>E.</given-names></name>, <name><surname>Dutra</surname><given-names>L.</given-names></name>, &amp; <name><surname>Westen</surname><given-names>D.</given-names></name></person-group> (<year>2005</year>). <article-title>A multidimensional meta-analysis of psychotherapy for PTSD</article-title>. <source/><italic>American Journal of Psychiatry</italic>, <volume>162</volume>(<issue>2</issue>), <fpage>214</fpage>–<lpage>227</lpage>. doi:<pub-id pub-id-type="doi">10.1176/appi.ajp.162.2.214</pub-id>
<pub-id pub-id-type="pmid">15677582</pub-id></mixed-citation>
</ref>
<ref id="CIT0003">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chung</surname><given-names>W.-S.</given-names></name>, <name><surname>Welsh</surname><given-names>C. A.</given-names></name>, <name><surname>Barres</surname><given-names>B. A.</given-names></name>, &amp; <name><surname>Stevens</surname><given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>Do glia drive synaptic and cognitive impairment in disease?</article-title>
<source/><italic>Nature Neuroscience</italic>, <volume>18</volume>(<issue>11</issue>), <fpage>1539</fpage>–<lpage>1545</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nn.4142</pub-id>
<pub-id pub-id-type="pmid">26505565</pub-id></mixed-citation>
</ref>
<ref id="CIT0004">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Deep-Soboslay</surname><given-names>A.</given-names></name>, <name><surname>Benes</surname><given-names>F. M.</given-names></name>, <name><surname>Haroutunian</surname><given-names>V.</given-names></name>, <name><surname>Ellis</surname><given-names>J. K.</given-names></name>, <name><surname>Kleinman</surname><given-names>J. E.</given-names></name>, &amp; <name><surname>Hyde</surname><given-names>T. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Psychiatric brain banking: Three perspectives on current trends and future directions</article-title>. <source/><italic>Biological Psychiatry</italic>, <volume>69</volume>, <fpage>104</fpage>–<lpage>112</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2010.05.025</pub-id>
<pub-id pub-id-type="pmid">20673875</pub-id></mixed-citation>
</ref>
<ref id="CIT0005">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Elsayed</surname><given-names>M.</given-names></name>, &amp; <name><surname>Magistretti</surname><given-names>P. J.</given-names></name></person-group> (<year>2015</year>). <article-title>A new outlook on mental illnesses: Glial involvement beyond the glue</article-title>. <source/><italic>Frontiers in Cellular Neuroscience</italic>, <volume>9</volume>, <fpage>468</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fncel.2015.00468</pub-id>
<pub-id pub-id-type="pmid">26733803</pub-id></mixed-citation>
</ref>
<ref id="CIT0006">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fragkaki</surname><given-names>I.</given-names></name>, <name><surname>Thomaes</surname><given-names>K.</given-names></name>, &amp; <name><surname>Sijbrandij</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Posttraumatic stress disorder under ongoing threat: A review of neurobiological and neuroendocrine findings</article-title>. <source/><italic>European Journal of Psychotraumatology</italic>, <volume>7</volume>, <fpage>30915</fpage>. doi:<pub-id pub-id-type="doi">10.3402/ejpt.v7.30915</pub-id>
<pub-id pub-id-type="pmid">27511448</pub-id></mixed-citation>
</ref>
<ref id="CIT0007">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lanius</surname><given-names>R.</given-names></name>, &amp; <name><surname>Olff</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>The neurobiology of PTSD</article-title>. <source/><italic>European Journal of Psychotraumatology</italic>, <volume>8</volume>(<issue>1</issue>), <page-range>1314165</page-range>. doi:<pub-id pub-id-type="doi">10.1080/20008198.2017.1314165</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0008">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lanius</surname><given-names>R. A.</given-names></name>, <name><surname>Frewen</surname><given-names>P. A.</given-names></name>, <name><surname>Tursich</surname><given-names>M.</given-names></name>, <name><surname>Jetly</surname><given-names>R.</given-names></name>, &amp; <name><surname>McKinnon</surname><given-names>M. C.</given-names></name></person-group> (<year>2015</year>). <article-title>Restoring large-scale brain networks in PTSD and related disorders: A proposal for neuroscientifically-informed treatment interventions</article-title>. <source/><italic>European Journal of Psychotraumatology</italic>, <volume>6</volume>, <fpage>27313</fpage>. doi:<pub-id pub-id-type="doi">10.3402/ejpt.v6.27313</pub-id>
<pub-id pub-id-type="pmid">25854674</pub-id></mixed-citation>
</ref>
<ref id="CIT0009">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marinova</surname><given-names>Z.</given-names></name>, &amp; <name><surname>Maercker</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Biological correlates of complex posttraumatic stress disorder—State of research and future directions</article-title>. <source/><italic>European Journal of Psychotraumatology</italic>, <volume>6</volume>, <fpage>25913</fpage>. doi:<pub-id pub-id-type="doi">10.3402/ejpt.v6.25913</pub-id>
<pub-id pub-id-type="pmid">25887894</pub-id></mixed-citation>
</ref>
<ref id="CIT0010">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Mizee</surname><given-names>M. R.</given-names></name>, <name><surname>van der Poel</surname><given-names>M.</given-names></name>, &amp; <name><surname>Huitinga</surname><given-names>I.</given-names></name></person-group> (<year>in press</year>). <source/><italic>Purification of cells from fresh bran tissue: Primary human glial cells. Handbook of Clinical Neurology</italic>, 150. Elsevier.</mixed-citation>
</ref>
<ref id="CIT0011">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nijdam</surname><given-names>M. J.</given-names></name>, &amp; <name><surname>Olff</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Erasing memory traces of trauma with eye movement desensitization and reprocessing therapy</article-title>. <source/><italic>European Journal of Psychotraumatology</italic>, <volume>7</volume>, <page-range>32545</page-range>. doi:<pub-id pub-id-type="doi">10.3402/ejpt.v7.32545</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0012">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nutt</surname><given-names>D. J.</given-names></name>, &amp; <name><surname>Malizia</surname><given-names>A. L.</given-names></name></person-group> (<year>2004</year>). <article-title>Structural and functional brain changes in posttraumatic stress disorder</article-title>. <source/><italic>The Journal of Clinical Psychiatry</italic>, <volume>65</volume>(<issue>Suppl 1</issue>), <fpage>11</fpage>–<lpage>17</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.03.037</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0013">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Olff</surname><given-names>M.</given-names></name>, <name><surname>Armour</surname><given-names>C.</given-names></name>, <name><surname>Brewin</surname><given-names>C.</given-names></name>, <name><surname>Cloitre</surname><given-names>M.</given-names></name>, <name><surname>Ford</surname><given-names>J.</given-names></name>, <name><surname>Herlihy</surname><given-names>J.</given-names></name>, et al</person-group> (<year>2015</year>). <article-title>Trauma and PTSD: Setting the research agenda</article-title>. <source/><italic>European Journal of Psychotraumatology</italic>, <volume>6</volume>, <fpage>28092</fpage>. doi:<pub-id pub-id-type="doi">10.3402/ejpt.v6.28092</pub-id>
<pub-id pub-id-type="pmid">25994028</pub-id></mixed-citation>
</ref>
<ref id="CIT0014">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Quidé</surname><given-names>Y.</given-names></name>, <name><surname>Witteveen</surname><given-names>A. B.</given-names></name>, <name><surname>El-Hage</surname><given-names>W.</given-names></name>, <name><surname>Veltman</surname><given-names>D. J.</given-names></name>, &amp; <name><surname>Olff</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Differences between effects of psychological versus pharmacological treatments on functional and morphological brain alterations in anxiety disorders and major depressive disorder: A systematic review</article-title>. <source/><italic>Neuroscience &amp; Biobehavioral Reviews</italic>, <volume>36</volume>, <fpage>626</fpage>–<lpage>644</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neubiorev.2011.09.004</pub-id>
<pub-id pub-id-type="pmid">21963442</pub-id></mixed-citation>
</ref>
<ref id="CIT0015">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Rademaker</surname><given-names>M. C.</given-names></name>, <name><surname>De Lange</surname><given-names>G. M.</given-names></name>, &amp; <name><surname>Palmen</surname><given-names>S. J. M. C.</given-names></name></person-group> (<year>in press</year>). <chapter-title>NBB-Psy: A prospective donor program for psychiatric diseases</chapter-title> In <source/><italic>Handbook of Clinical Neurology</italic>, 150. Elsevier.</mixed-citation>
</ref>
<ref id="CIT0016">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schnyder</surname><given-names>U.</given-names></name>, <name><surname>Ehlers</surname><given-names>A.</given-names></name>, <name><surname>Elbert</surname><given-names>T.</given-names></name>, <name><surname>Foa</surname><given-names>E. B.</given-names></name>, <name><surname>Gersons</surname><given-names>B. P.</given-names></name>, <name><surname>Resick</surname><given-names>P. A.</given-names></name>, … <name><surname>Cloitre</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Psychotherapies for PTSD: What do they have in common?</article-title>
<source/><italic>European Journal of Psychotraumatology</italic>, <volume>6</volume>, <fpage>28186</fpage>. doi:<pub-id pub-id-type="doi">10.3402/ejpt.v6.28186</pub-id>
<pub-id pub-id-type="pmid">26290178</pub-id></mixed-citation>
</ref>
<ref id="CIT0017">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seidler</surname><given-names>G. H.</given-names></name>, &amp; <name><surname>Wagner</surname><given-names>F. E.</given-names></name></person-group> (<year>2006</year>). <article-title>Comparing the efficacy of EMDR and trauma-focused cognitive-behavioral therapy in the treatment of PTSD: A meta-analytic study</article-title>. <source/><italic>Psychological Medicine</italic>, <volume>36</volume>(<issue>11</issue>), <fpage>1515</fpage>–<lpage>1522</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S0033291706007963</pub-id>
<pub-id pub-id-type="pmid">16740177</pub-id></mixed-citation>
</ref>
<ref id="CIT0018">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Steenkamp</surname><given-names>M. M.</given-names></name>, <name><surname>Litz</surname><given-names>B. T.</given-names></name>, <name><surname>Hoge</surname><given-names>C. W.</given-names></name>, &amp; <name><surname>Marmar</surname><given-names>C. R.</given-names></name></person-group> (<year>2015</year>). <article-title>Psychotherapy for military-related PTSD: A review of randomized clinical trials</article-title>. <source/><italic>Jama</italic>, <volume>314</volume>(<issue>5</issue>), <fpage>489</fpage>–<lpage>500</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2015.8370</pub-id>
<pub-id pub-id-type="pmid">26241600</pub-id></mixed-citation>
</ref>
<ref id="CIT0019">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Su</surname><given-names>Y. A.</given-names></name>, <name><surname>Wu</surname><given-names>J.</given-names></name>, <name><surname>Zhang</surname><given-names>L.</given-names></name>, <name><surname>Zhang</surname><given-names>Q.</given-names></name>, <name><surname>Su</surname><given-names>D. M.</given-names></name>, <name><surname>He</surname><given-names>P.</given-names></name>, … <name><surname>Osuch</surname><given-names>E.</given-names></name></person-group> (<year>2008</year>). <article-title>Dysregulated mitochondrial genes and networks with drug targets in postmortem brain of patients with posttraumatic stress disorder (PTSD) revealed by human mitochondria-focused cDNA microarrays</article-title>. <source/><italic>International Journal of Biological Sciences</italic>, <volume>4</volume>(<issue>4</issue>), <fpage>223</fpage>–<lpage>235</lpage>. doi:<pub-id pub-id-type="doi">10.7150/ijbs.4.223</pub-id>
<pub-id pub-id-type="pmid">18690294</pub-id></mixed-citation>
</ref>
<ref id="CIT0020">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Taylor</surname><given-names>S.</given-names></name></person-group> (<year>2006</year>). <source/><italic>Clinician’s guide to PTSD: A cognitive-behavioral approach</italic>. <publisher-loc>New York</publisher-loc>: <publisher-name>The Guildord Press</publisher-name>.</mixed-citation>
</ref>
<ref id="CIT0021">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thompson</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <source/>Unlocking the secrets of PTSD. <italic>Time</italic>, <volume>185</volume>(<issue>12</issue>), <fpage>40</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="pmid">25980055</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>